SCHEMBL4958690

SCHEMBL4958690

Nc1ccccc1C(=O)Nc1ccc(NC(=O)O)cc1C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.56
P2RX1 P51575 1/20 0.55
GRM4 Q14833 1/20 0.55
KDM4E B2RXH2 3/20 0.52
FADS1 O60427 2/20 0.50
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
ALDH1A1 P00352 1/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
HDAC1 Q13547 2/20 0.47
KCNK3 O14649 1/20 0.47
KCNK9 Q9NPC2 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
TAS2R14 Q9NYV8 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960584 0.95 PTGS1 (0.60) PTGS1P2RX1GRM4KDM4EFADS1
SCHEMBL5668547 0.83 PTGS1 (0.68) PTGS1P2RX1GRM4KDM4EFADS1
SCHEMBL5900421 0.82 PTGS1 (0.63) PTGS1P2RX1FADS1NPC1RAB9A
SCHEMBL4960684 0.81 P2RX1 (0.59) P2RX1GRM4KDM4ERAB9AALDH1A1
SCHEMBL4960692 0.81 P2RX1 (0.59) P2RX1GRM4KDM4ERAB9AALDH1A1
SCHEMBL31582888 0.81 FADS1 (0.67) PTGS1P2RX1GRM4FADS1NPC1
SCHEMBL4033804 0.81 FADS1 (0.67) PTGS1P2RX1GRM4FADS1NPC1
SCHEMBL5665935 0.80 FADS1 (0.66) PTGS1P2RX1GRM4FADS1RAB9A
SCHEMBL1011998 0.80 MAPT (0.67) PTGS1P2RX1FADS1NPC1RAB9A
SCHEMBL5668564 0.78 PTGS1 (0.64) PTGS1P2RX1GRM4FADS1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed